Cellevolve Bio Receives FDA Clearance of IND Application for CE-VST01-JC
25 Oct 2022 //
PRNEWSWIRE
Cellevolve and Seattle Children’s to develop CARs for paediatric cancers
10 Mar 2022 //
PHARMACEUTICAL-TECHNOLOGY
25 Oct 2022 //
PRNEWSWIRE
10 Mar 2022 //
PHARMACEUTICAL-TECHNOLOGY
Market Place
Sourcing Support